1. Home
  2. AEG vs ICLR Comparison

AEG vs ICLR Comparison

Compare AEG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEG
  • ICLR
  • Stock Information
  • Founded
  • AEG 1983
  • ICLR 1990
  • Country
  • AEG Netherlands
  • ICLR Ireland
  • Employees
  • AEG N/A
  • ICLR N/A
  • Industry
  • AEG Life Insurance
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • AEG Finance
  • ICLR Health Care
  • Exchange
  • AEG Nasdaq
  • ICLR Nasdaq
  • Market Cap
  • AEG 11.0B
  • ICLR 11.4B
  • IPO Year
  • AEG N/A
  • ICLR 1998
  • Fundamental
  • Price
  • AEG $7.28
  • ICLR $150.10
  • Analyst Decision
  • AEG Strong Buy
  • ICLR Buy
  • Analyst Count
  • AEG 1
  • ICLR 12
  • Target Price
  • AEG N/A
  • ICLR $204.18
  • AVG Volume (30 Days)
  • AEG 9.1M
  • ICLR 1.2M
  • Earning Date
  • AEG 01-01-0001
  • ICLR 07-23-2025
  • Dividend Yield
  • AEG 2.56%
  • ICLR N/A
  • EPS Growth
  • AEG N/A
  • ICLR 11.53
  • EPS
  • AEG 0.39
  • ICLR 9.19
  • Revenue
  • AEG $13,292,266,284.00
  • ICLR $8,192,621,999.00
  • Revenue This Year
  • AEG N/A
  • ICLR N/A
  • Revenue Next Year
  • AEG $2.01
  • ICLR $2.10
  • P/E Ratio
  • AEG $17.68
  • ICLR $16.33
  • Revenue Growth
  • AEG N/A
  • ICLR N/A
  • 52 Week Low
  • AEG $5.42
  • ICLR $125.10
  • 52 Week High
  • AEG $7.32
  • ICLR $347.72
  • Technical
  • Relative Strength Index (RSI)
  • AEG 62.17
  • ICLR 60.50
  • Support Level
  • AEG $7.15
  • ICLR $142.89
  • Resistance Level
  • AEG $7.31
  • ICLR $155.25
  • Average True Range (ATR)
  • AEG 0.08
  • ICLR 4.79
  • MACD
  • AEG 0.03
  • ICLR 0.51
  • Stochastic Oscillator
  • AEG 94.12
  • ICLR 65.78

About AEG Aegon Ltd. New York Registry Shares

Aegon is a life insurance and long-term savings business listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: